Star Bulk Carriers Corp. reports Q1 results today with the most striking signal sitting not in short positioning — which is minimal — but in an options market that has swung to its most defensive reading in nearly a year, just as the stock gives back ground against a softer dry bulk backdrop.
The clearest tension is in the options market. Put/call ratio has surged to 4.34, more than 2.6 standard deviations above its 20-day average of 3.33 — the highest reading in a year, and close to the 52-week peak of 4.53. That jump happened in a single session: the PCR had been running between 3.0 and 3.5 for most of the past month before spiking sharply on May 18–19. Options traders are loading up on downside protection right at the earnings print, a clear expression of caution around the outcome.
Short interest tells a very different and much calmer story. Bears hold just 1.3% of the free float short — a low-conviction level by any measure — and that figure has barely moved in a month. Borrow cost runs at 0.46%, down 27% over the past 30 days, and availability is effectively unlimited: more than 30 million shares remain available to lend relative to the roughly 1.5 million already out on loan. The lending market has loosened dramatically from late April, when availability was tighter, and now shows zero friction for anyone wanting to initiate or add a short position. The short score of 29.5 reflects that, ranking in the 75th percentile of the broader universe but driven more by the options dynamic than by any fundamental crowding in the borrow.
The Street is cautiously constructive. Jefferies initiated coverage with a Buy in late April, setting a $29 target against a current price of $26.08 — roughly 14% upside implied. Three buy ratings are on the board and no sells, though the analyst consensus score ranks in the 93rd percentile for divergence from the current price. Valuation is undemanding: the stock trades at 7.2x trailing earnings and 6.1x EV/EBITDA, with the EV/EBITDA multiple down roughly 10% over the past 30 days as the price retreated from its recent highs. The bull case rests on a balance sheet carrying $452 million in cash, a 21% net loan-to-value ratio, and Q4 bookings that management described as the strongest since early 2024. Bears point to Kamsarmax rates running 15% below their July 2025 peak and a Q3 2025 EPS miss, with adjusted earnings at $0.28 against a $0.32 consensus.
The ownership picture adds a layer of nuance. The register is heavily anchored: C.K. Limited and John Fredriksen between them hold nearly 24% of shares, and both reported no change in their last filings. On the selling side, COO Nikolaos Rescos sold roughly 33,200 shares across two transactions this week at around $26.28–$26.49, collecting close to $870,000 in proceeds. That follows an April sale of a further 10,000 shares. Director Raffaele Zagari sold 11,500 shares in late March. On the other hand, Milena-Maria Pappas added 2.7 million shares in her March filing, and Two Sigma and Marshall Wace both made material additions in Q1. Net insider activity over 90 days runs to a positive 54,700 shares — the Pappas buying outweighs the COO sales by volume — but the cluster of COO selling ahead of today's earnings report is worth noting.
The sector isn't offering much lift. Closest peer GNK has fallen nearly 8% on the week, and DSX is off 4.7%. HSHP dropped 5% over the same period. SBLK's own 4.6% weekly decline is toward the moderate end of the peer spectrum — but the group is broadly under pressure, suggesting macro headwinds rather than stock-specific weakness. The two prior earnings events on record show mixed reactions: a 5.5% gain on the day following the February 2026 Q4 print, but a flat to negative 5-day outcome. The print before that, from Q3 2025, delivered a 5.6% one-day gain.
With earnings landing today, the focus sharpens on whether forward rate commentary can close the gap between the near-record options defensiveness and the Street's continued buy-side consensus.
See the live data behind this article on ORTEX.
Open SBLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.